14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 03, 2024 Sell 10 451 Roth David Common Stock
Apr 02, 2024 Sell 150 Roth David Common Stock
Apr 01, 2024 Sell 4 218 Stephens Kristin Common Stock
Apr 01, 2024 Sell 14 052 Simonian Nancy A Common Stock
Apr 01, 2024 Sell 4 732 Roth David Common Stock
Apr 01, 2024 Sell 4 732 Haas Jason Common Stock
Apr 01, 2024 Sell 3 500 Chee Conley Common Stock
Mar 31, 2024 Buy 11 666 Stephens Kristin Common Stock
Mar 31, 2024 Sell 11 666 Stephens Kristin Restricted Stock Units
Mar 31, 2024 Buy 2 000 Stephens Kristin Common Stock
Mar 31, 2024 Sell 2 000 Stephens Kristin Restricted Stock Units
Mar 31, 2024 Buy 39 566 Simonian Nancy A Common Stock
Mar 31, 2024 Buy 6 000 Simonian Nancy A Common Stock
Mar 31, 2024 Sell 39 566 Simonian Nancy A Restricted Stock Units
Mar 31, 2024 Sell 6 000 Simonian Nancy A Restricted Stock Units
Mar 31, 2024 Sell 13 333 Roth David Restricted Stock Units
Mar 31, 2024 Buy 13 333 Roth David Common Stock
Mar 31, 2024 Sell 2 000 Roth David Restricted Stock Units
Mar 31, 2024 Buy 2 000 Roth David Common Stock
Mar 31, 2024 Buy 13 333 Haas Jason Common Stock
Mar 31, 2024 Sell 13 333 Haas Jason Restricted Stock Units
Mar 31, 2024 Buy 2 000 Haas Jason Common Stock
Mar 31, 2024 Sell 2 000 Haas Jason Restricted Stock Units
Mar 31, 2024 Buy 11 666 Chee Conley Common Stock
Mar 31, 2024 Sell 11 666 Chee Conley Restricted Stock Units
Mar 31, 2024 Buy 2 000 Chee Conley Common Stock
Mar 31, 2024 Sell 2 000 Chee Conley Restricted Stock Units
Mar 28, 2024 Sell 7 046 Quirk Gerald E Common Stock
Mar 27, 2024 Buy 22 500 Quirk Gerald E Common Stock
Mar 27, 2024 Sell 22 500 Quirk Gerald E Restricted Stock Units
Dec 21, 2023 Buy 904 977 Akkaraju Srinivas Common Stock
Dec 12, 2023 Sell 6 287 Roth David Common Stock
Dec 06, 2023 Sell 6 287 Roth David Common Stock
Dec 02, 2023 Buy 86 000 Chee Conley Restricted Stock Units
Dec 01, 2023 Sell 7 500 Simonian Nancy A Stock Option (right to buy)
Dec 01, 2023 Sell 17 499 Simonian Nancy A Stock Option (right to buy)
Dec 01, 2023 Sell 28 001 Simonian Nancy A Stock Option (right to buy)
Dec 01, 2023 Sell 29 399 Simonian Nancy A Stock Option (right to buy)
Dec 01, 2023 Sell 30 399 Simonian Nancy A Stock Option (right to buy)
Nov 01, 2023 Sell 13 401 Simonian Nancy A Common Stock
Nov 01, 2023 Sell 6 301 Haas Jason Common Stock
Nov 01, 2023 Sell 6 301 Roth David Common Stock
Nov 01, 2023 Sell 5 676 Stephens Kristin Common Stock
Nov 01, 2023 Sell 6 004 Chee Conley Common Stock
Oct 31, 2023 Buy 40 125 Simonian Nancy A Common Stock
Oct 31, 2023 Sell 40 125 Simonian Nancy A Restricted Stock Units
Oct 31, 2023 Buy 18 875 Haas Jason Common Stock
Oct 31, 2023 Sell 18 875 Haas Jason Restricted Stock Units
Oct 31, 2023 Buy 18 875 Roth David Common Stock
Oct 31, 2023 Sell 18 875 Roth David Restricted Stock Units
Oct 31, 2023 Buy 17 000 Stephens Kristin Common Stock
Oct 31, 2023 Sell 17 000 Stephens Kristin Restricted Stock Units
Oct 31, 2023 Buy 17 000 Chee Conley Common Stock
Oct 31, 2023 Sell 17 000 Chee Conley Restricted Stock Units
Oct 19, 2023 Sell 6 897 Quirk Gerald E Common Stock
Oct 11, 2023 Buy 22 500 Quirk Gerald E Common Stock
Oct 11, 2023 Sell 22 500 Quirk Gerald E Restricted Stock Units
Sep 16, 2023 Buy 2 666 Young Richard A Common Stock
Sep 16, 2023 Sell 2 666 Young Richard A Restricted Stock Units
Sep 16, 2023 Sell 2 666 Alles Mark J Restricted Stock Units
Sep 16, 2023 Buy 2 666 Alles Mark J Common Stock
Sep 16, 2023 Sell 2 666 Akkaraju Srinivas Restricted Stock Units
Sep 16, 2023 Buy 2 666 Akkaraju Srinivas Common Stock
Sep 12, 2023 Buy 30 000 Quirk Gerald E Restricted Stock Units
Jul 31, 2023 Sell 7 348 Roth David Common Stock
Jul 17, 2023 Sell 689 Olson Eric R Common Stock
Jun 01, 2023 Buy 4 000 Young Richard A Common Stock
Jun 01, 2023 Buy 6 000 Young Richard A Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Wirth Peter Common Stock
Jun 01, 2023 Buy 6 000 Wirth Peter Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Tyson Timothy Common Stock
Jun 01, 2023 Buy 6 000 Tyson Timothy Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Oh Andrew M. Common Stock
Jun 01, 2023 Buy 6 000 Oh Andrew M. Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Fanucci Marsha Common Stock
Jun 01, 2023 Buy 6 000 Fanucci Marsha Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Eckhardt Sue Gail Common Stock
Jun 01, 2023 Buy 6 000 Eckhardt Sue Gail Stock Option (right to buy)
Jun 01, 2023 Buy 6 000 Dunsire Deborah Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Dunsire Deborah Restricted Stock Units
Jun 01, 2023 Buy 6 000 Alles Mark J Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Alles Mark J Restricted Stock Units
Jun 01, 2023 Buy 6 000 Akkaraju Srinivas Stock Option (right to buy)
Jun 01, 2023 Buy 4 000 Akkaraju Srinivas Restricted Stock Units
Mar 31, 2023 Sell 2 000 Haas Jason Restricted Stock Units
Sep 16, 2022 Buy 12 000 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 257 Tyson Timothy Common Stock
Sep 16, 2022 Buy 8 000 Tyson Timothy Common Stock
Sep 16, 2022 Buy 3 856 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 3 856 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 3 286 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 2 848 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 2 232 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 2 191 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 2 191 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 1 094 Tyson Timothy Stock Option (right to buy)
Sep 16, 2022 Buy 691 489 Akkaraju Srinivas Common Stock
Sep 16, 2022 Buy 691 489 Akkaraju Srinivas Warrants (right to buy)
Sep 16, 2022 Buy 12 000 Akkaraju Srinivas Stock Option (right to buy)
Sep 16, 2022 Buy 8 000 Akkaraju Srinivas Restricted Stock Units
INSIDER POWER
51.970
Last 100 transactions
Buy: 2 824 203 | Sell: 497 307 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 51.970.

In total, the insiders bought 2 824 203 and sold 497 307 SYRS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Syros Pharmaceuticals

Syros Pharmaceuticals Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acu... SYRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT